(Q41066477)

26 September 2017

1 reference

title

Drug interactions with antiviral drugs (English)

1 reference

26 September 2017

A M Taburet

1

1 reference

26 September 2017

E Singlas

series ordinal

2

1 reference

26 September 2017

publication date

1 May 1996

1 reference

Clinical Pharmacokinetics

26 September 2017

published in

1 reference

26 September 2017

volume

30

1 reference

26 September 2017

issue

5

1 reference

26 September 2017

page(s)

385-401

1 reference

3'-azido-3'-deoxythymidine drug interactions. Screening for inhibitors in human liver microsomes

26 September 2017

cites work

1 reference

12 December 2020

Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine

1 reference

12 December 2020

Pancreatic lesions in HIV-infected patients

1 reference

12 December 2020

Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis

1 reference

12 December 2020

Overview of antiretroviral therapy

1 reference

12 December 2020

1 reference

12 December 2020

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection

1 reference

12 December 2020

Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys

1 reference

12 December 2020

Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

12 December 2020

Clinical pharmacokinetics of nucleoside antiretroviral agents

1 reference

12 December 2020

Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients

1 reference

12 December 2020

Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus

1 reference

12 December 2020

Effect of antacids in didanosine tablet on bioavailability of isoniazid

1 reference

12 December 2020

Absorption interactions with fluoroquinolones. 1995 update

1 reference

12 December 2020

Drug interactions of clinical importance. An updated guide

1 reference

12 December 2020

Effect of metoclopramide and loperamide on the pharmacokinetics of didanosine in HIV seropositive asymptomatic male and female patients.

1 reference

12 December 2020

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Itraconazole-didanosine excipient interaction

1 reference

12 December 2020

Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study

1 reference

12 December 2020

The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects

1 reference

12 December 2020

Clinical pharmacokinetics of amantadine hydrochloride.

1 reference

12 December 2020

Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals

1 reference

12 December 2020

Pharmacokinetics of 2',3'-dideoxyinosine in patients with severe human immunodeficiency infection. II. The effects of different oral formulations and the presence of other medications.

1 reference

12 December 2020

Perspectives in drug therapy of HIV infection

1 reference

12 December 2020

Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.

1 reference

12 December 2020

Pharmacokinetic Optimisation of Antiretroviral Therapy in Patients with HIV Infection

1 reference

12 December 2020

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

12 December 2020

Prevalence and patterns of use of concomitant medications among participants in three multicenter human immunodeficiency virus type I clinical trials. AIDS Clinical Trials Group (ACTG).

1 reference

12 December 2020

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection

1 reference

12 December 2020

Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients

1 reference

12 December 2020

Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.

1 reference

12 December 2020

HIV therapy advances. Update on a proteinase inhibitor

1 reference

12 December 2020

Pharmacokinetics of co-administered didanosine and stavudine in HIV-seropositive male patients

1 reference

12 December 2020

Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine

1 reference

12 December 2020

Cations in the didanosine tablet reduce ciprofloxacin bioavailability.

1 reference

12 December 2020

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

1 reference

12 December 2020

Reduction of 3'-azido-3'-deoxythymidine to 3'-amino-3'-deoxythymidine in human liver microsomes and its relationship to cytochrome P450

1 reference

12 December 2020

Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Pharmacokinetic drug interactions with antimicrobial agents

1 reference

12 December 2020

Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus

1 reference

12 December 2020

Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)

1 reference

12 December 2020

Does drug interaction cause failure of PCP prophylaxis with dapsone?

1 reference

12 December 2020

Clinical Pharmacokinetics of Interferons

1 reference

12 December 2020

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Combination therapy: more effective control of HIV type 1?

1 reference

12 December 2020

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions

1 reference

12 December 2020

Failure of prophylaxis with dapsone in patients taking dideoxyinosine

1 reference

12 December 2020

Hepatotoxicity of paracetamol in combination with interferon and vinblastine

1 reference

12 December 2020

Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS)

1 reference

12 December 2020

Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis

1 reference

12 December 2020

Combination Antiretroviral Therapy

1 reference

12 December 2020

Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections

1 reference

12 December 2020

Drug interactions with antacids. Mechanisms and clinical significance

1 reference

12 December 2020

Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection

1 reference

12 December 2020

Zalcitabine. Clinical pharmacokinetics and efficacy.

1 reference

12 December 2020

In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)

1 reference

12 December 2020

The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes

1 reference

12 December 2020

Inosine pranobex and zidovudine metabolism

1 reference

12 December 2020

Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection

1 reference

12 December 2020

Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

P450 enzymes. Inhibition mechanisms, genetic regulation and effects of liver disease

1 reference

12 December 2020

Comparative pharmacokinetics of antiviral nucleoside analogues

1 reference

12 December 2020

Drug interactions with zidovudine

1 reference

12 December 2020

Adverse effects and drug interactions of clinical importance with antiviral drugs

1 reference

12 December 2020

10.2165/00003088-199630050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

1030971040

0 references

1 reference